June 9, 2023 – Mount Sinai Health System recently hosted a ribbon-cutting ceremony for the newly constructed Mount Sinai-Behavioral Health Center, located in Lower Manhattan
The $140 million facility—believed to be the largest private investment in mental health care in New York State history—will transform behavioral health care in New York City by serving as a comprehensive “one-stop shop” for mental health care, substance use treatment, and primary care.
The new center features a robust, integrated continuum of behavioral health services all under one roof. In addition to inpatient care, it will provide critically needed intensive outpatient and crisis services, including a Partial Hospitalization Program, an Intensive Outpatient Program, and one of New York State’s first Intensive Crisis Residences. The Intensive Crisis Residence is a short-term therapeutic residence in a home-like setting for people experiencing acute mental health crises that are not severe enough to require hospitalization. It can also serve as a step-down from an acute hospital stay to help patients transition more safely back into the community. At the new center, general outpatient mental health and substance use disorder treatment services are integrated with primary care services, providing seamless access and comprehensive care for our communities’ overall health needs.
In addition, the Mount Sinai-Behavioral Health Center will serve as a hub for innovation, continually expanding and improving behavioral health services available in New York City. By bringing these services under one roof and adding critical new programs, this center will offer a full continuum of care, an integrated process to coordinate care, and a seamless system to access other specialized behavioral health services across the Mount Sinai Health System.
Mount Sinai-Behavioral Health Center’s transformation of the current system for behavioral health treatment goes hand in hand with basic and clinical research. The new center is part of Mount Sinai’s Department of Psychiatry, a national leader in basic and clinical research with $59 million in grant funding in 2022, more than 40 labs, 130 research faculty members, and 15 major research centers. All patients of the Center will have the opportunity to participate in research and clinical trials that contribute to the advancement of psychiatric knowledge and care. These trials provide early and exclusive access to innovative therapeutic approaches that could have beneficial, life-changing outcomes.